Valuation: Telix Pharmaceuticals Limited

Market Cap 6.03B 4.3B 3.73B 3.52B 3.19B 5.99B 413B 42.04B 16.17B 209B 16.16B 15.8B 667B P/E 2026 *
229x
P/E 2027 * 205x
Enterprise Value 6.46B 4.61B 3.99B 3.77B 3.42B 6.41B 442B 45.02B 17.32B 224B 17.3B 16.92B 714B EV / Sales 2026 *
4.71x
EV / Sales 2027 * 4.17x
Free-Float
83.1%
Yield 2026 *
-
Yield 2027 * -
1 day-6.51%
1 week-0.57%
Current month+8.04%
1 month+0.88%
3 months+19.82%
6 months+51.14%
Current year+48.17%
1 week 15.5
Extreme 15.5
18.22
1 month 14.86
Extreme 14.86
18.22
Current year 8.26
Extreme 8.26
18.22
1 year 8.26
Extreme 8.26
18.32
3 years 8.2
Extreme 8.2
31.97
5 years 3.55
Extreme 3.55
31.97
10 years 0.46
Extreme 0.46
31.97
Manager TitleAgeSince
Chief Executive Officer 51 03/01/2017
Director of Finance/CFO 61 31/07/2022
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 51 03/01/2017
Chairman 66 03/02/2026
Director/Board Member 68 19/06/2018
Date Insider Type Main position Quantity % Market Cap. Importance
26/5/26 Free

Director

21,597 0.0064%
26/5/26 Free

Founder

339,845 0.1001%
26/5/26 Free

Director

21,597 0.0064%
Change 5-day change 1-year change 3-year change Capi.($)
-6.37%-0.57%+17.70%+43.93% 4.3B
+0.56%-3.38%-1.83%+8.00% 45.81B
-0.12%-1.19%+343.42%+545.03% 43.91B
+1.51%+4.04%+45.01%+27.38% 44.39B
-2.07%-1.42%+4.28%+72.97% 39.4B
-0.73%-3.06%+9.63%+38.92% 31.26B
-9.49%-11.23% - - 15.75B
+4.21%+5.01%+24.99%+121.62% 17.32B
+1.83%+3.20%+16.49%+32.73% 14.73B
-0.08%-2.81%+79.24%+31.27% 13.03B
Average -1.09%-1.03%+59.88%+102.43% 26.99B
Weighted average by Cap. -0.35%-1.20%+75.74%+129.02%

Financials

2026 *2027 *
Net sales 1.37B 979M 848M 802M 726M 1.36B 93.9B 9.57B 3.68B 47.61B 3.68B 3.6B 152B 1.56B 1.12B 966M 913M 827M 1.55B 107B 10.9B 4.19B 54.23B 4.19B 4.1B 173B
Net income 27.54M 19.64M 17.01M 16.09M 14.56M 27.33M 1.88B 192M 73.85M 955M 73.77M 72.14M 3.05B 482K 344K 298K 282K 255K 479K 33M 3.36M 1.29M 16.73M 1.29M 1.26M 53.36M
Net Debt 427M 305M 264M 250M 226M 424M 29.23B 2.98B 1.15B 14.82B 1.14B 1.12B 47.26B 496M 353M 306M 289M 262M 492M 33.9B 3.45B 1.33B 17.19B 1.33B 1.3B 54.82B
Logo Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.
Employees
1,152
Date Price Change Volume
16/09/26 $16.69 -5.97% 2,955,349
15/09/26 $17.75 +8.63% 6,277,577
14/09/26 $16.34 +4.28% 4,723,800
11/09/26 $15.67 -6.50% 2,193,327
10/09/26 $16.76 +0.42% 1,759,963
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
17.75AUD
Average target price
24.00AUD
Spread / Average Target
+35.21%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!